$DXCM

2 theses

bullish 50%neutral 50%bearish 0%

Avg return (3m)

+25.0%

Win rate (3m)

100% (1 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Nov 2, 4:15 PM ET

$DXCMr/ValueInvestingDiscussionneutral

u/Idntevncare · 88d ago8 prior · awaiting results

HEALTHCARE is a great value right now

Dexcom is mentioned as a comparison point for MMED valuation; author suggests MMED's revenue generation relative to DXCM's 31B market cap indicates potential mispricing in the biotech/medical device space.

At post $83.02Now $84.76+2.1% since postedas of Nov 2, 4:15 PM ET

1d+2.1%

3d+2.1%

1w+9.7%

1m+5.9%

3m—

6m—

1y—

original post →

$DXCMr/wallstreetbetsYOLObullish

u/EmptyCash5704 · 165d agono track record yet

“41K bet (image reference)”

41K bet on DXCM turnaround play

CGM technology mainstream adoption, revenue growth acceleration, margin expansion, Stelo product success, and type 2 diabetes coverage expansion will drive a revaluation away from depressed medical device valuation.

At post $71.90Now $84.76+17.9% since postedas of Nov 2, 4:15 PM ET

1d+0.3%

3d+0.3%

1w+0.6%

1m+0.8%

3m+25.0%

6m—

1y—

original post →

End of results.